Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)Michael Pfreundschuh, Markus Loeffler, Eva Lengfelder et al.|The Lancet Oncology|2008Cited by 1.1k
A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic ProfilingMichael Hummel, Reiner Siebert, Stefan Bentink et al.|New England Journal of Medicine|2006Cited by 1k
Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registryAlessandro Pastore, Oliver Weigert, Vindi Jurinović et al.|The Lancet Oncology|2015Cited by 613
Efficacy of Histologic Criteria for Diagnosing Early Mycosis FungoidesMarco Santucci, Günter Burg, Annibale Biggeri et al.|The American Journal of Surgical Pathology|2000Cited by 143